| Identification | Back Directory | [Name]
N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide dihydrochloride hydrate | [CAS]
595584-40-0 | [Synonyms]
CJB090 dihydrochloride
CJB-090 dihydrochloride
CJB 090 dihydrochloride
CJB 090 dihydrochloride hydrate
N-(4-(4-(2,3-dichlorophenyl)piperazin-1-yl)butyl)-4-(pyridin-2-yl)benzamide dihydrochloride hydrate | [Molecular Formula]
C26H32Cl4N4O2 | [MDL Number]
MFCD20488056 | [MOL File]
595584-40-0.mol | [Molecular Weight]
574.37 |
| Chemical Properties | Back Directory | [Melting point ]
234-237 °C | [storage temp. ]
2-8°C | [solubility ]
H2O: ≥18mg/mL | [form ]
powder | [color ]
white to tan | [Water Solubility ]
H2O: ≥18mg/mL |
| Hazard Information | Back Directory | [Biological Activity]
CJB 090 is a Dopamine D3 receptor partial agonist. CJB 090 was found to attenuate the discriminative stimulus (DS) effects of cocaine while showing no cocaine-like effects when tested aloneand has also been shown to reduce methamphetamine self-administration. |
|
| Company Name: |
Merck KGaA
|
| Tel: |
21-20338288 |
| Website: |
www.sigmaaldrich.cn |
|